Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/37921
Title: | Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022 | Authors: | ROBIJNS, Jolien LODEWIJCKX, Joy Arany, Praveen Barasch, Andrei Jan, Bjordal Bossi, Paolo Chilles, Anne Corby, Patricia Epstein, Joel Elad, Sharon Fekrazad, Reza Fregnani, Eduardo Genot, Marie-Thérèse Ibarra, Ana Hamblin, Michael Heiskanen, Vladimir Hu, Ken Klastersky, Jean Lalla, Raj Latifian, Sofia Maiya, Arun MEBIS, Jeroen Migliorati, Cesar Milstein, Dan Murhpy, Barbara Raber-Durlacher, Judith Roseboom, Hendrik Sonis, Stephen Treister, Nathaniel Zadik, Yehuda Bensadoun, René-Jean |
Issue Date: | 2022 | Publisher: | FRONTIERS MEDIA SA | Source: | Frontiers in oncology, | Status: | In press | Abstract: | Disclaimer: This article is based on recommendations from the 12 th WALT Congress, Nice, October 3-6, 2018, and a follow-up review of the existing data and the clinical observations of an international multidisciplinary panel of clinicians and researchers with expertise in the area of supportive care in cancer and/or PBM clinical application and dosimetry. This article is informational in nature. As with all clinical materials, this paper should be used with a clear understanding that continued research and practice could result in new insights and recommendations. The review reflects the collective opinion and, as such, does not necessarily represent the opinion of any individual author. In no event shall the authors be liable for any decision made or action taken in reliance on the proposed protocols. Objective: This position paper reviews the potential prophylactic and therapeutic effects of photobiomodulation (PBM) on side effects of cancer therapy, including chemotherapy (CT), radiation therapy (RT), and hematopoietic stem cell transplantation (HSCT). Background: There is a considerable body of evidence supporting the efficacy of PBM for preventing oral mucositis (OM) in patients undergoing RT for head and neck cancer (HNC), CT, or HSCT. This could enhance patients' quality of life, adherence to the prescribed cancer therapy, and treatment outcomes while reducing the cost of cancer care. | Keywords: | photobiomodulation (PBM);cancer supportive care;guidelines;recommendations;mucositis;dermatitis;cancer-treatment side effects | Document URI: | http://hdl.handle.net/1942/37921 | ISSN: | 2234-943X | e-ISSN: | 2234-943X | DOI: | 10.3389/fonc.2022.927685 | ISI #: | 000855538900001 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2023 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Position Paper PBM Cancer Supp Care.pdf | Non Peer-reviewed author version | 1.28 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.